Mucolyte
NDC 57237-359, Guaifenesin, liquid, from Rising Pharma Holdings, Inc..
- Product NDC
- 57237-359
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57237-359 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN100 mg/5mL
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57237-359-12 | 57237035912 | 118 mL in 1 BOTTLE (57237-359-12) |
| 57237-359-16 | 57237035916 | 473 mL in 1 BOTTLE (57237-359-16) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 57237035912
GET /v1/drugs/nadac/57237035912NADAC price for package 57237035916
GET /v1/drugs/nadac/57237035916
Use it
Look up 57237-359 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57237-359 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57237-359. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.